ClearOne Takes $200K Non-Interest-Bearing Loan Days After Nasdaq Delisting Notice
CLRO is trading near its 52-week low of $2.71 (12% above the low).
Summary
ClearOne raised $200,000 via a non-interest-bearing, unsecured, no-maturity loan from First Finance Ltd., disclosed one day after Nasdaq moved to delist the company. The bridge capital funds general working capital while the Cortigent merger and a $15M unit offering remain pending.
Key Events · Financing and Capital Events · CLRO
-
First Finance Loan of $200,000
ClearOne entered a Loan Agreement with First Finance Ltd. for $200,000, advanced October 7, 2026 and documented October 14. The loan is unsecured and non-interest-bearing.
-
No Maturity Date, No Interest
Repayment is due on a date to be mutually agreed in writing, with no fixed term and no interest accruing even during default. ClearOne may prepay at any time without penalty.
-
Follows Nasdaq Delisting Determination
The loan was disclosed one day after Nasdaq determined to delist ClearOne for failing to meet the $2.5 million minimum stockholders' equity requirement (8-K filed 2026-10-13).
-
Proceeds for Working Capital
ClearOne expects to use the $200,000 for general working capital purposes, adding to a balance sheet already carrying a going-concern warning.
Analysis · CLRO · Manufacturing
ClearOne borrowed $200,000 from First Finance Ltd. on October 7, 2026, formalized in a Loan Agreement dated October 14. The loan is unsecured, pays no interest, and has no maturity date — repayment is deferred until the two sides agree in writing. That structure is not what a commercial lender offers; it is bridge capital from a related party (First Finance's president, Andrew Hromyk, signed the agreement) meant to keep the lights on. The timing is the story: this comes one day after Nasdaq determined to delist ClearOne for failing to meet the $2.5 million minimum stockholders' equity requirement, and against a backdrop of a going-concern warning, a pending reverse merger with Cortigent, and a $15 million unit offering at $3.50 per unit that has not yet closed. $200,000 is small in absolute terms but meaningful for a company this size — it buys weeks, not quarters, of working capital. The absence of a maturity date and interest rate means the real risk is not default on this loan but whether the Cortigent merger or the unit offering closes before cash runs out.
How filings like this one have moved
In the 30 days to Oct 29, 2026, 31% of the 1656 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.01%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CLRO was trading at $3.03 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $8.4M. The 52-week trading range was $2.71 to $16.50. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.